Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112849 · ClinicalTrials.gov registry record
Electronic S3 Prediction of Hospital Readmissions for HF Exacerbation
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 28
- Enrollment target
NCT04112849 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 28 participants.
The verdict
NCT04112849 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The study objective is to measure the value of the third heart sound (S3) for the prediction of recurrent heart failure (HF). For the purpose of this study, a heart failure event will be defined as a hospitalization with a primary diagnosis of heart failure. The main hypothesis of the study is that measurement of S3, using a microelectronic machine microphone positioned in a wearable device (Nanowear Wearable Congestive Heart Failure Management System) near the time of discharge from a hospitalization for heart failure, can predict which patients will be at high risk for a heart failure event, thereby identifying a group in whom increased surveillance and monitoring may decrease hospital readmissions for worsening heart failure.
Interventions
- DIAGNOSTIC_TEST Measurement of S3 heart sound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-03-11 |
| Est. Completion | 2022-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04112849
The ClinicalTrials.gov registry entry for NCT04112849 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Measurement of S3 heart sound is the first listed.
NCT04112849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04112849 about?
NCT04112849 is a clinical study titled "Electronic S3 Prediction of Hospital Readmissions for HF Exacerbation". The study objective is to measure the value of the third heart sound (S3) for the prediction of recurrent heart failure (HF). For the purpose of this study, a heart failure event will be defined as a hospitalization with a primary diagnosis of heart failure. The main hypothesis of the study is that ...
What is the current status of trial NCT04112849?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2020-03-11. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT04112849?
The interventions under investigation include: Measurement of S3 heart sound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04112849?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.